Irhythm Technologies: Buy Rating Reaffirmed as Cyberattack Seen as Non-Material; $255 Price Target Maintained
at www.tipranks.com (Thu, 16-Jul 6:25 AM)
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX)
at www.tipranks.com (Wed, 15-Jul 8:20 AM)
